2 news items
MAIA Biotechnology (MAIA) to Showcase Groundbreaking Telomere-Targeting Cancer Treatments at BIO International Convention 2024
AFMD
ALBT
BPTH
4 Jun 24
functions by inducing telomeric DNA damage and boosting cancer-specific immune responses, potentially offering a new pathway for cancer treatment where
La Rosa Appoints Corporate Finance Executive Lourdes Felix to its Board of Directors
ALBT
BICX
LRHC
21 May 24
Rosa does not undertake any responsibility to update any forward-looking statements in this release, except as may be required by applicable law
- Prev
- 1
- Next